DIRS.INFO The most relevant business & tech news

☆ Sunrun stock could double in value as company shifts to solar energy storage, Jeffries says
▼ + stars: | 2024-02-22 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

Sunrun could see its stock price double over the next 12 months as the company is well positioned to take advantage of growth in the residential solar market after a disappointing 2023, according to Jeffries. Sunrun's stock was down nearly 9% in morning trading on Thursday after the company posted a steeper fourth-quarter loss than Wall Street expected and missed revenue estimates. The company's net subscriber value of $13,445 in the fourth quarter came in 12% above consensus estimates, Ailani wrote. Ailani's new price target is based on Sunrun's future subscriber growth plus the present value of its existing customers. Jeffries is estimating that Sunrun will add about 121,000 new subscribers in 2024, which is 7% above consensus estimates.

Persons: Jeffries, Dushyant Ailani, Sunrun, Ailani, — CNBC's Michael Bloom Organizations: Wall

☆ Chip analysts boost Nvidia price targets in race to catch up to chipmaker's relentless 'joyride'
▼ + stars: | 2024-02-22 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

That led several Wall Street banks to hike their price targets to account for the unrelenting demand. Bernstein and other Wall Street shops raced to catch up with Nvidia's share price, hiking their price targets in reaction to nonstop demand and the company's enormous total addressable market. Rasgon's new target was the equivalent of 48% upside from Wednesday's close, while the average price target according to FactSet implied more than 22% upside. Bank of America's Vivek Arya also lifted his Nvidia price target to $925 per share, equal to about 37% upside. JPMorgan analyst Harlan Sur boosted his price target to $850 to reflect strong data center growth and future product launches.

Persons: Bernstein's Stacy Rasgon, Bernstein, America's Vivek Arya, Harlan Sur, allaying, Sur, Goldman Sachs, Toshiya Hari, Morgan Stanley's Joseph Moore, Moore, Deutsche Bank's Ross Seymore, Seymore, Timothy Arcuri, Arcuri, — CNBC's Michael Bloom Organizations: Nvidia, Bank, America's, JPMorgan, Deutsche, UBS Locations: CY24

☆ Buy these stocks that Oppenheimer sees having upside potential
▼ + stars: | 2024-02-22 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Oppenheimer has refreshed its monthly list of top stocks to include several new tech names. With this in mind, analysts Oppenheimer refreshed its list of top picks in the market. New additions to the list include NXP Semiconductors , CyberArk Software , AppLovin and Expedia . Take a look at some of the other names on the list below, and where Oppenheimer analysts see them going forward. CYBR YTD mountain CyberArk Software shares Athleisure company Lululemon is another one of Oppenheimer's favorite picks.

Persons: Oppenheimer, NXP, Rick Schafer, Ittai Kidron, Brian Nagel, Nagel, LULU, CNBC's Michael Bloom Organizations: Semiconductors, CyberArk, Software Locations: Netherlands

☆ JPMorgan reveals its favorite European stock picks — giving one over 93% upside
▼ + stars: | 2024-02-22 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +1 min

JPMorgan uncovered several top European stocks it says offer substantial upside potential — as well as some "unattractive" names — right now. The bank is underweight on the euro zone, given that its "Growth-Policy trade-off" is "likely to deteriorate further." Nevertheless, JPMorgan sees pockets of opportunity in the European market. Here are five stocks from its list of "top European picks" which stand out for having substantial upside potential, according to FactSet's consensus price targets: 'Unattractive stocks' JPMorgan also revealed its list of "unattractive stocks" from a sector it's underweight on — banking. Stocks named as " unattractive" include Lloyds Banking Group , BNP Paribas , Svenska Handelsbanken AB and Bank of Ireland Group .

Persons: Mislav Matejka, Banks, Stocks, — CNBC's Michael Bloom Organizations: JPMorgan, Lloyds Banking Group, BNP, Svenska Handelsbanken, Bank of Ireland Group

☆ A 'messy' quarter: What analysts are saying after Rivian's latest quarterly report
▼ + stars: | 2024-02-22 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Analysts are growing cautious on Rivian shares as its struggles are worsened by weak electric vehicle demand. RBC has a $15 per share price target, which is roughly 3% below Wednesday's close of $15.39. RIVN 1D mountain Rivian stock. Narayan said legacy automakers are in a better position to navigate the current slowdown in EV demand, and said he expects Rivian stock to "to come under pressure." Langan lowered his price target to $14 per share from $18.

Persons: Rivian, Tom Narayan, expected.It, Narayan, FactSet, Wells, Colin M, Langan, Goldman Sachs, Mark Delaney, Delaney, — CNBC's Michael Bloom Organizations: RBC Capital, RBC, Barclays Locations: Wednesday's

☆ These dividend stocks are poised for a rebound, according to BMO
▼ + stars: | 2024-02-21 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Dividend stocks have come under pressure in today's higher interest rate environment as investors have turned to bonds with juicy yields. They all have a next-twelve-months price-to-earnings ratio lower than the index and a dividend yield higher than the index. It has a 4.3% dividend yield and has gained about 1% year to date. Another utility play, Exelon , has a 4% dividend yield and is also up less than 1% so far this year. Lastly, investment banking giant Morgan Stanley has slipped nearly 9% so far this year and has a 4% dividend yield.

Persons: Brian Belski, Belski, Hunter C, Gary, Exelon, Gilead, Morgan Stanley, Ted Pick, — CNBC's Michael Bloom Organizations: BMO Capital Markets, American Electric, American Electric Power, Icahn Capital, Gilead Sciences, Therapeutics Locations: U.S

☆ Here are Wednesday's biggest analyst calls: Amazon, Target, Dell, Microsoft, HP, SolarEdge, Norfolk Southern & more
▼ + stars: | 2024-02-21 | by ( Michael Bloom | ) www.cnbc.com time to read: +5 min

"Downgrade to Reduce (from Hold) while retaining target price of USD323 on valuation and lack of near-term catalysts." JPMorgan reiterates Amazon as a top idea JPMorgan said it sees further share gains for shares of Amazon. Redburn Atlantic Equities reiterates Microsoft as buy Redburn said it sees Microsoft's Azure gaining market share in cloud. Wells Fargo reiterates Target as overweight Wells raised its price target on the stock to $165 per share from $155. "We are initiating coverage of ChargePoint Holdings, Inc. with a Buy rating and a $4.25 Price Target.

Persons: Piper Sandler, Piper, Redburn, Cantor Fitzgerald, Cantor, Wells, Morgan Stanley, Dell, it's, DELL, Jefferies, Stifel, Goldman Sachs, Goldman, SEDG Organizations: Street, HSBC downgrades, HSBC, Home, JPMorgan, Palo Alto Networks, billings, Barclays, Norfolk, Walgreens Boots Alliance, Walgreens, Microsoft, Sabre Corporation, Dell, EV, ChargePoint Holdings, Inc, UBS, HP

☆ Beware these value traps, Wolfe Research says
▼ + stars: | 2024-02-21 | by ( Brian Evans | ) www.cnbc.com time to read: +4 min

Some stocks on Wall Street that are attractively valued could come with a steep catch, according to Wolfe Research. With stocks starting to fall, investors may begin to think some names are a good value when they are not. Wolfe screened for potential value traps in a note Thursday. Short interest hovers at 5% of the company's float, and Wolfe noted Walgreens' anticipated earnings deceleration of 165% is a warning sign for the stock. WBA YTD mountain Walgreens stock.

Persons: Wolfe, Stocks, Michael Bloom Organizations: Wolfe Research, Caesars Entertainment, LSEG, Caesars Palace, FactSet, Caesars, Walgreens Boots Alliance, Walgreens, WBA, Dow Jones, ViaSat, Alaska Air, Shift4

☆ What to expect from Nvidia earnings after the stock's 'recent parabolic run-up'
▼ + stars: | 2024-02-21 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

Some Wall Street analysts are bracing for a pullback in Nvidia shares after the chipmaker reports fiscal fourth quarter results after the bell Wednesday. "We reiterate Buy/top pick ahead of NVDA Feb-21 earnings but won't be surprised to see a notable but brief pullback after the recent parabolic run-up in the stock," wrote Bank of America analyst Vivek Arya in a recent note. Nvidia shares slid more than 4% during Tuesday's session, but they have surged 40% in 2024. "Hence, we see limited room for further earnings upside in 2024 relative to the sales and earnings surprise that we saw in 2023." Even if Nvidia tops estimates, some on Wall Street anticipate a post-earnings decline akin to what's occurred during previous prints.

Persons: NVDA, Vivek Arya, Frank Lee, Tom O'Malley, Morgan Stanley's Joseph Moore, haven't, Rosenblatt, Raymond James, Srini Pajjuri, O'Malley, Timothy Arcuri, Evercore ISI's Julian Emanuel, — CNBC's Michael Bloom Organizations: Nvidia, Bank of America, HSBC, Barclays, UBS

☆ Want steady, passive income? Buy these dividend stocks with higher yields, Wall Street says
▼ + stars: | 2024-02-21 | by ( Weizhen Tan | ) www.cnbc.com time to read: +4 min

Dividend stocks came under the spotlight after Meta unexpectedly announced a dividend for the first time. BofA has also been bullish on dividend stocks lately, saying investors may flock back to such stocks for income if yields fall this year, in turn driving up this segment of stocks. Wall Street and other pros share their tips on how to pick good dividend stocks and what names will generate sustainable income. In fact, using that strategy mitigates the risk of relying only on dividend income if higher rates affect dividend distributions, according to Stutland. "This combination provides a buffer against future interest rate hikes and offers the possibility of capital appreciation alongside dividend income."

Persons: Meta, BofA, Brian Stutland, Stutland, Goldman, Stocks, It's, — CNBC's Michael Bloom Organizations: CNBC Pro, Morningstar, Walmart, Target, Depot, Verizon, Treasury

☆ SolarEdge might not recover until 2025 as residential solar market struggles to bounce back
▼ + stars: | 2024-02-21 | by ( Spencer Kimball | ) www.cnbc.com time to read: +5 min

SolarEdge might not recover until early 2025 as the company remains saddled with inventory in Europe and faces weak demand in the U.S., signs that the residential solar market in particular is struggling to bounce back in the face of high interest rates. Citi said SolarEdge remains a high-risk stock with the investment bank slashing its price target by $6 to $83. Cho rates SolarEdge as underweight with a price target of $50, implying 40% downside from Tuesday's close. SolarEdge CEO Lando did provide some brighter news Tuesday, forecasting that the European residential solar sector will bottom in the current quarter and improve thereafter. Investors might receive further insight on where the solar market goes from here when residential installers Sunrun and Sunnova report earnings after the bell Wednesday.

Persons: Zvi Lando, Goldman Sachs, Brian Lee, SolarEdge, Vikram Bagri, Bagri, Ronen Faier, Christine Cho, Cho, Enphase, Badri Kothandaraman, Kothandaraman, Lando, — CNBC's Michael Bloom Organizations: Citi, Barclays, CNBC, Investors Locations: Europe, U.S

☆ Here are Tuesday's biggest analyst calls: Nvidia, Apple, Tesla, JetBlue, Disney, Caterpillar, Super Micro and more
▼ + stars: | 2024-02-20 | by ( Michael Bloom | ) www.cnbc.com time to read: +9 min

Here are Tuesday's biggest calls on Wall Street: Morgan Stanley downgrades Oatly to equal weight from overweight Morgan Stanley resumed coverage of the oats company and said it sees too many negative catalysts. " Morgan Stanley reiterates Tesla as overweight Morgan Stanley said it's sticking with Tesla despite a slew of negative data points in a recent investor survey. Morgan Stanley reiterates Nvidia as overweight Morgan Stanley said it's standing by Nvidia heading into earnings later this week. Morgan Stanley initiates CG Oncology as buy Morgan Stanley said shares of the bladder cancer company are "compelling." "We initiate coverage on Morgan Stanley Direct Lending with a Buy rating and $23.50 PT.

Persons: Morgan Stanley downgrades Oatly, Morgan Stanley, Tesla, Bernstein, Siri, it's, Disney, Ingersoll Rand, Rosenblatt, MSCI's, Goldman Sachs, Wolfe, Piper Sandler, Riley, Grainger, Northcoast, JPMorgan downgrades Holley Organizations: Apple, Nvidia, Disney, RBC, Aerospace, BAE Systems, Caterpillar, SMCI, Deutsche Bank, JetBlue, Alaska Air, ASM, Health, BrightSpring Health, Brunswick Corporation, Barclays, JPMorgan, Mizuho, Oncology, UBS, Morgan, Fund, Seaport, Booking Holdings, " Bank of America, AIG, Bank of America, General Insurance Locations: Silicon Valley, Alaska, Brunswick, MIBS, Texas, Europe, Asia

☆ Rosenblatt calls for more than 60% upside on Super Micro Computer after stock's massive rally
▼ + stars: | 2024-02-20 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Super Micro Computer has soared more than 182% since the start of the year, but the chipmaker has even more upside potential ahead thanks to artificial intelligence tailwinds, according to Rosenblatt. Another key factor in Super Micro's growth story is its liquid cooling solutions for data centers, Mosesmann added. Traditional chipmakers have been less adept in this segment, which opens the door for Super Micro to achieve "heightened hyper-scale engagement," according to the analyst. "The anticipation of increased research coverage should further illuminate Supermicro's business model and the opportunities in its [total addressable market]." Shares of Super Micro were up nearly 3% Tuesday during premarket trading.

Persons: Rosenblatt, Hans Mosesmann, Mosesmann, Wells, — CNBC's Michael Bloom Organizations: Micro Locations: Friday's

☆ JPMorgan says buy this immunology stock primed to rally nearly 40%
▼ + stars: | 2024-02-20 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Immunovant could emerge as a key player in the autoimmune space, according to JPMorgan. The bank initiated coverage of the biotech stock at an overweight rating, also setting a price target of $51. That implies that shares of Immunovant could rally more than 37% from their Friday closing price of $37.13. Immunovant stock has slid 9% so far this quarter. IMVT YTD mountain IMVT YTD chart As a key catalyst, the analyst underscored Immunovant's stats as one of the key players using anti-neonatal Fc receptor technology, or anti-FcRn technology, to treat autoimmune diseases.

Persons: Brian Cheng, Graves, Cheng, — CNBC's Michael Bloom Organizations: JPMorgan, IMVT, Telavant, Merck, Prometheus Locations: Immunovant, IMVT, Roche

☆ 'Hidden gems': UBS names 5 global small-cap stocks — giving one 77% upside
▼ + stars: | 2024-02-20 | by ( Ganesh Rao | ) www.cnbc.com time to read: +1 min

UBS has uncovered small- and medium-sized overlooked stocks across Europe that offer substantial upside potential. Of those, the five stocks below stand out for having the biggest upside potential, according to FactSet's consensus price targets. The five stocks had a high UBS "composite value score," indicating they are cheap relative to their book value. Finally, UBS screened for stocks with a relatively low short-selling in them — the practice of betting on the stocks falling. The bank had previously said small- and mid-cap companies are a "preferred" segment for investing in 2024.

Persons: Sutanya Chedda, — CNBC's Michael Bloom Organizations: UBS Locations: Europe

☆ 'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights
▼ + stars: | 2024-02-19 | by ( Michelle Fox | ) www.cnbc.com time to read: +14 min

There's been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Attention to a long-time crisis The mental health crisis is nothing new. However, there has also been a growing awareness and acceptance of mental health illnesses over the past decade, said Canaccord Genuity analyst Richard Close. "There's been recognition that mental health has a significant impact on a person's overall health," he said. "This is the mental health moment," said Dr. Ken Duckworth, NAMI's chief medical officer and author of "You Are Not Alone: The NAMI Guide to Mental Health."

Persons: There's, Covid, Peter Micca, AbbVie, Emraclidine, Myers Squibb, Karuna, Marc Goodman, Canaccord, Richard Close, MacKenzie Scott, Ken Duckworth, NAMI, Deloitte's Micca, William Blair, Myles Minter, Minter, Auvelity, Leerink's Goodman, Ashwani Verma, Verma, Goodman, BioHaven, Cerevel, Neumora, tardive, David Song, BetterHelp, psychedelics Johnson, Johnson, Spravato, Blair's Minter, Axsome, Micca, Michael Bloom Organizations: Institute for Health Metrics, Deloitte, Cerevel Therapeutics, Karuna Therapeutics, Bristol Myers, Leerink Partners, Centers for Disease Control, National Alliance, Mental, Mental Health, Wall Street, Therapeutics, Neumora Therapeutics, UBS, Karuna, Cellular Therapies, Xenon Pharmaceuticals, Neurocrine Biosciences, Acadia Pharmaceuticals, Tema Neuroscience, Axsome Therapeutics, Acadia Healthcare, BetterHelp, CNBC, pharma, Cellular Locations: Covid, Bristol, XEN1101, Acadia, Tema

☆ I bought a house in Japan for less than $45,000. I live in the peaceful countryside close to every convenience, and everything's cheaper here.
▼ + stars: | 2024-02-19 | by ( Jordan Pandy | ) www.businessinsider.com time to read: +8 min

Ned Watson bought a home in Japan that had been abandoned for two years for less than $50,000. The lack of guns and violence is one of the best things about Japan. My house was abandoned for two years, but didn't need much workI've been living in Japan since 2010, and I got this house in late 2019. I could basically live this lifestyle forever for $20,000 a year, which to me is not a lot of money. So really think about the area that the place is in, what type of personal infrastructure you're going to need to live there.

Persons: Ned Watson, Watson, I've, they're, you'll, It's, that's, it's, you've, I'm, Ned — he's Organizations: Tokyo Station Locations: Japan, Shisui, Japan's Chiba Prefecture, Australia, Georgia, America, New York City, Tokyo, Chiba Prefecture, Narita City, Narita, Watson's

☆ These options plays can help investors profit from a pullback in stocks, Goldman says
▼ + stars: | 2024-02-18 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +3 min

Those options could be relatively cheap right now for some of the more vulnerable stocks, according to Goldman. "During normal market environments, the options market prices options efficiently based on trailing realized volatility. Our long-term studies have shown that Free Cash Flow is the most important fundamental metric to watch when estimating downside asymmetry," Marshall said in the note. To identify put option candidates, Goldman found stocks trading above the firm's price targets and low or negative free cash flow. That company reported a net loss of $116.6 million in 2023 , with free cash flow of just $7.9 million.

Persons: John Marshall, Goldman Sachs, Goldman, Marshall, — CNBC's Michael Bloom Organizations: Southwest Airlines, LUV, Tech, Intel, Southwest

☆ Goldman Sachs likes these five stocks coming out of earnings, including this hot chip name
▼ + stars: | 2024-02-17 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Analysts at Goldman Sachs have highlighted a handful of tech stocks with upside as earnings season begins to wind down. The S & P 500 tech sector posted an earnings growth rate of 21.6% in the fourth quarter. Arm Analyst Toshiya Hari is standing by shares of the semiconductor and software design company. Arm delivered a blowout fiscal third-quarter earnings report earlier this month, and the sky is the limit for the company, according to the firm. ASML The semiconductor company posted beats on its latest earnings report , but warned that it expects sales to be flat this year compared to 2023.

Persons: Goldman Sachs, Hari, Kash Rangan, Rangan, Monday.com, Alexander Duval, Duval, ASML, ANET Organizations: Goldman, CNBC, Arista Networks, Arm Holdings, ASML, Data Center, Automotive, Microsoft, Nvidia, TAM, …, Software Locations: China

Cornish, a professor at Ohio State University who studies rubber alternatives, isn't the only one pouring energy into alternative crops like that desert shrub, guayule, or the rubber dandelions that bloom with yellow petals in the greenhouse where Cornish works. And in Nebraska and other parts of the central U.S., green grasses of sorghum spring up, waving with reddish clusters of grains. Instead, they're crops that many companies, philanthropic organizations and national and international entities tout as promising alternatives to fight climate change. Most rubber processing happens overseas, and the U.S. isn't prepared to process rubber domestically. That's why specialty markets will be critical if these crops have any hope of taking off here, Cornish said.

Persons: Katrina Cornish, guayule, isn't, Cornish, Nate Blum, Blum, James Gerber, Gerber, there's, It’s, ”, Tesla, Guayule, Bill Niaura, “ You’re, Curt Covington, Covington, Joshua A . Bickel, Ross D, Franklin, Melina Walling Organizations: Ohio State University, Bridgestone, U.S, Agriculture Organization, AgAmerica, Farmers, Associated Press Locations: United States, Arizona, Nebraska, U.S, India, Saharan Africa, South Asia, Americas, Colorado, Wooster , Ohio, Eloy , Arizona, AP.org

☆ Nvidia gets a $1,200 price target from Loop Capital, 65% above current price
▼ + stars: | 2024-02-16 | by ( Samantha Subin | ) www.cnbc.com time to read: +1 min

Nvidia 's powerhouse run is far from over, according to Loop Capital. Analyst Ananda Baruah initiated coverage of the chipmaker with a buy rating and Wall Street price target high of $1,200, representing 65% upside from Thursday close. NVDA 1Y mountain Nvidia shares over the last year "We're gonna party like it's 1995!" Underpinning Baruah's price target is the belief that Nvidia is at the "front end" of a multiyear cycle as hyperscalers transition to greater graphics processing unit compute. Heightened IT spending and budgets as companies hunt for ways to harness AI as they convert more data to the cloud should also bode well for Nvidia, Baruah said, noting that budgets are expected to increase to 45% from 30% in 2023.

Persons: Ananda Baruah, We're, bode, Baruah, — CNBC's Michael Bloom Organizations: Nvidia, Capital, AMD

☆ Stocks making the biggest moves midday: Coinbase, Roku, Nike, Super Micro Computer and more
▼ + stars: | 2024-02-16 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

Coinbase Global — Shares surged nearly 16% after the cryptocurrency exchange reported its first profit in two years. Roku — The streaming service provider slid 24% after posting a larger-than-expected loss for the fourth quarter. Dropbox — Shares shed 20% after the cloud storage company issued lower-than-expected first-quarter revenue guidance. Dropbox now forecasts revenue in the range of $627 million to $630 million, versus the $632.5 million expected from analysts polled by FactSet. Super Micro Computer — The information technology company shed 11.6% after Wells Fargo initiated coverage of the stock with an equal weight rating.

Persons: Coinbase's, Yelp, FactSet, Toast, DoorDash, Wells, Carvana, Raymond James, —, Samantha Subin, Sarah Min, Alex Harring, Pia Singh Organizations: LSEG, Revenue, Nike —, Oppenheimer, FactSet, Bloom Energy, Nvidia —, Loop Locations: Carvana's

☆ Morgan Stanley ponders if Eli Lilly could be the first $1 trillion pharma stock on weight loss boom
▼ + stars: | 2024-02-16 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +3 min

On Friday, Flynn raised his price target on Lilly shares to $950 from $805. With Lilly's stock closing Thursday at $757.78, the target suggests 25% more upside ahead. LLY 1Y mountain Eli Lilly shares over the past year. "LLY is establishing high barriers to entry in the diabesity market," Flynn said, adding that this is what contributes to its higher valuation. Phase 3 data is expected on orforglipron in 2025, which Flynn sees as a catalyst for the stock to go higher.

Persons: Eli Lilly, Morgan Stanley, Terence Flynn, Flynn, Lilly, Mounjaro, — CNBC's Michael Bloom Organizations: Novo Nordisk Locations: diabesity

☆ Here are Friday's biggest analyst calls: Nvidia, Nike, Tesla, Coinbase, Arm, Meta, Eli Lilly, UPS, Carvana & more
▼ + stars: | 2024-02-16 | by ( Michael Bloom | ) www.cnbc.com time to read: +9 min

Here are Friday's biggest calls on Wall Street: Bank of America reiterates Meta as buy Bank of America said it's bullish on Meta adding the Broadcom CEO to its board of directors. Bank of America reiterates Nvidia as buy Bank of America said it's standing by the stock heading into earnings next week but that a pullback is possible. Baird upgrades UPS to outperform from neutral Baird said in its upgrade of UPS that the risk/reward is too attractive to ignore. Bank of America downgrades Dropbox to underperform from buy Bank of America said the "bull thesis has played out" for the data storage company. Bank of America upgrades Cellebrite to buy from neutral Bank of America said it sees business trends stabilizing for the digital intelligence company.

Persons: it's, Hock Tan, NVDA, Goldman Sachs, Goldman, TD Cowen, Grosvenor, KBW, TTD, Baird, Wells, Tommy Hilfiger, Tommy, Raymond James downgrades Carvana, Raymond James, Wayfair, Oppenheimer, Morgan Stanley, Tesla, Guggenheim, SunPower, Jefferies, Eli Lilly, Roku Organizations: Bank of America, Meta, Broadcom, " Bank of America, Nvidia, Informatica, BMO, Trade, Google, U.S, UPS, JPMorgan, Daiwa, CY2025, UBS, Newell Brands, RBC, Nike, of America, Barclays, Netflix, JPMorgan downgrades Bloom Energy, BE, Pharma Locations: CY24, CY2024, Wayfair, U.S

☆ Wall Street cheers Coinbase after its first quarterly profit in 2 years, but skepticism lingers
▼ + stars: | 2024-02-16 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +8 min

Wall Street is celebrating Coinbase after the crypto exchange operator posted its first quarterly profit in two years. Late Thursday, Coinbase posted earnings of $1.04 per share on $954 million of revenue for the fourth quarter. "Happy days are here again" for Coinbase, as Raymond James put it, but it's not clear for how long. "That said, we maintain our U/P rating given crypto market unpredictability, lack of revenue diversification, valuation, and continued legal overhang." JPMorgan, neutral, PT $95 "Management calls spot bitcoin ETFs [a] net positive but, we're still unconvinced," said JPMorgan's Kenneth Worthington.

Persons: Coinbase, haven't, bitcoin, Raymond James, Goldman Sachs, Goldman, Will Nance, revs, Jason Kupferberg, Benjamin Budish, EBITDA, underperform, Patrick O'Shaughnessy, we're, Kenneth Worthington, Keefe, KBW's Kyle Voigt, Oppenheimer, Owen Lau, Devin Ryan, Needham, John Todaro, Canaccord, Joseph Vafi, Michael Bloom Organizations: LSEG, U.S . Securities, Exchange Commission, " Bank of America, Bank of America, Barclays, JPMorgan, Management, SEC, Coinbase's, BTC Locations: U.S, Coinbase, Needham

Search resuls for: "BLOOM"

25 mentions found